M
PTHS

Murchinson’s Pelthos Therapeutics PTHS Stock Holding History

Murchinson’s Portfolio PTHS Stock Details PTHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.6M Buy
304,302
+7,988
+3% +$205K 1.19% 24
2026
Q1 		$6.23M Buy
296,314
+6,835
+2% +$162K 0.79% 25
2025
Q4 		$8.97M Buy
289,479
+9,479
+3% +$273K 1.44% 15
2025
Q3 		$7.84M Buy
+280,000
New +$6.8M 0.99% 11

Other funds holding PTHS

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Murchinson's PTHS Position: Q2 2026 in Review

Murchinson increased its Pelthos Therapeutics (PTHS) stake by 2.7% in Q2 2026, buying an estimated $205K and bringing the position to 304,302 shares worth $8.6M. The position accounts for 1.19% of the portfolio, ranked #24.

Murchinson first reported a position in PTHS in Q3 2025 and has held it in 4 quarters since. The position peaked at $8.97M in Q4 2025. 24 funds tracked by Wall St. Rank hold PTHS as of Q2 2026.

  • Murchinson held 304,302 shares of Pelthos Therapeutics worth $8.6M as of Q2 2026.
  • Murchinson bought 7,988 Pelthos Therapeutics shares in Q2 2026, an estimated $205K.
  • Pelthos Therapeutics made up 1.19% of Murchinson's portfolio in Q2 2026, its #24 holding.
  • Murchinson first reported a position in Pelthos Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Murchinson's Pelthos Therapeutics position peaked at $8.97M in Q4 2025.
  • 24 funds tracked by Wall St. Rank held Pelthos Therapeutics as of Q2 2026.

Based on Murchinson's 13F filing for Q2 2026, filed 14 Aug 2026.